Clinical evaluation of five different automated SARS-CoV-2 serology assays in a cohort of hospitalized COVID-19 patients

[1]  David C. Yeo,et al.  Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays , 2020, Journal of Clinical Virology.

[2]  M. Plebani,et al.  Diagnostic performances and thresholds: The key to harmonization in serological SARS-CoV-2 assays? , 2020, Clinica Chimica Acta.

[3]  A. Azman,et al.  Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward , 2020, Science Immunology.

[4]  C. Bethel,et al.  Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies , 2020, bioRxiv.

[5]  E. Theel,et al.  The Role of Antibody Testing for SARS-CoV-2: Is There One? , 2020, Journal of Clinical Microbiology.

[6]  Jun Yuan,et al.  Antibody responses to SARS-CoV-2 in patients with COVID-19 , 2020, Nature Medicine.

[7]  R. Davey,et al.  Detection of Nucleocapsid Antibody to SARS-CoV-2 is More Sensitive than Antibody to Spike Protein in COVID-19 Patients , 2020, medRxiv.

[8]  K. Krogfelt,et al.  Evaluation of nine commercial SARS-CoV-2 immunoassays , 2020, medRxiv.

[9]  Qi Jin,et al.  Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19) , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  Susanne Pfefferle,et al.  Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[11]  Victor M Corman,et al.  Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.